Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Armelle Caty

Showing results (11-20 of 19) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 19 results.
Clinical Genitourinary Cancer|December 15, 2016
Prognostic Value of Baseline Neutrophil-to-Lymphocyte Ratio in Metastatic Urothelial Carcinoma Patients Treated With First-line Chemotherapy: A Large Multicenter StudyMarie Auvray, Reza Elaidi, Mustafa Ozguroglu, et al.
European Urology|October 8, 2013
A risk-adapted study of cisplatin and etoposide, with or without ifosfamide, in patients with metastatic seminoma: results of the GETUG S99 multicenter prospective studyKarim Fizazi, Rémi Delva, Armelle Caty, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 19, 2008
Randomized trial comparing bleomycin/etoposide/cisplatin with alternating cisplatin/cyclophosphamide/doxorubicin and vinblastine/bleomycin regimens of chemotherapy for patients with intermediate- and poor-risk metastatic nonseminomatous germ cell tumors: Genito-Urinary Group of the French Federation of Cancer Centers Trial T93MPStéphane Culine, Andrew Kramar, Christine Théodore, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 11, 2012
Complete remission with tyrosine kinase inhibitors in renal cell carcinomaLaurence Albiges, Stéphane Oudard, Sylvie Negrier, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|August 19, 2009
Phase III trial of vinflunine plus best supportive care compared with best supportive care alone after a platinum-containing regimen in patients with advanced transitional cell carcinoma of the urothelial tractJoaquim Bellmunt, Christine Théodore, Tomasz Demkov, et al.
Acta Oncologica (Stockholm, Sweden)|May 31, 2014
Efflux pump ABCB1 single nucleotide polymorphisms and dose reductions in patients with metastatic renal cell carcinoma treated with sunitinibBenoit Beuselinck, Diether Lambrechts, Thomas Van Brussel, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|August 1, 2018
Sunitinib Prior to Planned Nephrectomy in Metastatic Renal Cell Carcinoma: Angiogenesis Biomarkers Predict Clinical Outcome in the Prospective Phase II PREINSUT TrialLaetitia Mauge, Arnaud Mejean, Laure Fournier, et al.
JAMA Oncology|February 1, 2019
Effect of Adding Docetaxel to Androgen-Deprivation Therapy in Patients With High-Risk Prostate Cancer With Rising Prostate-Specific Antigen Levels After Primary Local Therapy: A Randomized Clinical TrialStéphane Oudard, Igor Latorzeff, Armelle Caty, et al.
European Journal of Cancer (Oxford, England : 1990)|May 27, 2017
Metastatic chromophobe renal cell carcinoma treated with targeted therapies: A Renal Cross Channel Group studyEmeline Colomba, Gwénaël Le Teuff, Tim Eisen, et al.
Pageof 2

Showing results (11-20 of 19) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 19 results.
Clinical Genitourinary Cancer|December 15, 2016
Prognostic Value of Baseline Neutrophil-to-Lymphocyte Ratio in Metastatic Urothelial Carcinoma Patients Treated With First-line Chemotherapy: A Large Multicenter StudyMarie Auvray, Reza Elaidi, Mustafa Ozguroglu, et al.
European Urology|October 8, 2013
A risk-adapted study of cisplatin and etoposide, with or without ifosfamide, in patients with metastatic seminoma: results of the GETUG S99 multicenter prospective studyKarim Fizazi, Rémi Delva, Armelle Caty, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 19, 2008
Randomized trial comparing bleomycin/etoposide/cisplatin with alternating cisplatin/cyclophosphamide/doxorubicin and vinblastine/bleomycin regimens of chemotherapy for patients with intermediate- and poor-risk metastatic nonseminomatous germ cell tumors: Genito-Urinary Group of the French Federation of Cancer Centers Trial T93MPStéphane Culine, Andrew Kramar, Christine Théodore, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 11, 2012
Complete remission with tyrosine kinase inhibitors in renal cell carcinomaLaurence Albiges, Stéphane Oudard, Sylvie Negrier, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|August 19, 2009
Phase III trial of vinflunine plus best supportive care compared with best supportive care alone after a platinum-containing regimen in patients with advanced transitional cell carcinoma of the urothelial tractJoaquim Bellmunt, Christine Théodore, Tomasz Demkov, et al.
Acta Oncologica (Stockholm, Sweden)|May 31, 2014
Efflux pump ABCB1 single nucleotide polymorphisms and dose reductions in patients with metastatic renal cell carcinoma treated with sunitinibBenoit Beuselinck, Diether Lambrechts, Thomas Van Brussel, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|August 1, 2018
Sunitinib Prior to Planned Nephrectomy in Metastatic Renal Cell Carcinoma: Angiogenesis Biomarkers Predict Clinical Outcome in the Prospective Phase II PREINSUT TrialLaetitia Mauge, Arnaud Mejean, Laure Fournier, et al.
JAMA Oncology|February 1, 2019
Effect of Adding Docetaxel to Androgen-Deprivation Therapy in Patients With High-Risk Prostate Cancer With Rising Prostate-Specific Antigen Levels After Primary Local Therapy: A Randomized Clinical TrialStéphane Oudard, Igor Latorzeff, Armelle Caty, et al.
European Journal of Cancer (Oxford, England : 1990)|May 27, 2017
Metastatic chromophobe renal cell carcinoma treated with targeted therapies: A Renal Cross Channel Group studyEmeline Colomba, Gwénaël Le Teuff, Tim Eisen, et al.
Pageof 2